Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 13, 2023

SELL
$57.89 - $64.73 $521 - $582
-9 Reduced 0.19%
4,742 $275,000
Q2 2023

Jul 21, 2023

BUY
$63.71 - $70.74 $3,695 - $4,102
58 Added 1.24%
4,751 $303,000
Q1 2023

Apr 07, 2023

SELL
$65.71 - $74.53 $394 - $447
-6 Reduced 0.13%
4,693 $325,000
Q4 2022

Jan 18, 2023

BUY
$68.48 - $81.09 $7,806 - $9,244
114 Added 2.49%
4,699 $0
Q3 2022

Oct 14, 2022

BUY
$0.13 - $76.84 $2 - $1,536
20 Added 0.44%
4,585 $320,000
Q2 2022

Jul 27, 2022

SELL
$72.62 - $79.98 $163,758 - $180,354
-2,255 Reduced 33.06%
4,565 $352,000
Q1 2022

Apr 22, 2022

BUY
$61.48 - $73.72 $2,766 - $3,317
45 Added 0.66%
6,820 $498,000
Q4 2021

Jan 19, 2022

SELL
$53.63 - $62.52 $30,140 - $35,136
-562 Reduced 7.66%
6,775 $422,000
Q3 2021

Oct 13, 2021

SELL
$59.17 - $69.31 $35,620 - $41,724
-602 Reduced 7.58%
7,337 $434,000
Q2 2021

Jul 14, 2021

SELL
$61.91 - $67.42 $384,708 - $418,947
-6,214 Reduced 43.91%
7,939 $530,000
Q1 2021

Apr 28, 2021

BUY
$59.34 - $66.74 $130,251 - $146,494
2,195 Added 18.36%
14,153 $894,000
Q4 2020

Jan 22, 2021

BUY
$57.74 - $65.43 $7,794 - $8,833
135 Added 1.14%
11,958 $742,000
Q2 2020

Jul 15, 2020

BUY
$54.82 - $64.09 $2,466 - $2,884
45 Added 0.38%
11,823 $695,000
Q1 2020

Apr 10, 2020

BUY
$46.4 - $67.43 $30,995 - $45,043
668 Added 6.01%
11,778 $657,000
Q4 2019

Jan 14, 2020

BUY
$49.21 - $64.19 $60,872 - $79,403
1,237 Added 12.53%
11,110 $713,000
Q3 2019

Oct 16, 2019

SELL
$42.77 - $50.71 $1,539 - $1,825
-36 Reduced 0.36%
9,873 $501,000
Q2 2019

Jul 24, 2019

BUY
$44.62 - $49.34 $1,561 - $1,726
35 Added 0.35%
9,909 $449,000
Q1 2019

Apr 19, 2019

BUY
$45.12 - $53.8 $82,253 - $98,077
1,823 Added 22.64%
9,874 $471,000
Q4 2018

Jan 22, 2019

SELL
$48.76 - $63.23 $38,617 - $50,078
-792 Reduced 8.96%
8,051 $418,000
Q3 2018

Oct 19, 2018

SELL
$55.19 - $62.25 $4,470 - $5,042
-81 Reduced 0.91%
8,843 $549,000
Q2 2018

Aug 06, 2018

SELL
$50.53 - $62.98 $18,544 - $23,113
-367 Reduced 3.95%
8,924 $494,000
Q1 2018

May 01, 2018

BUY
$59.92 - $68.98 $14,201 - $16,348
237 Added 2.62%
9,291 $588,000
Q4 2017

Feb 05, 2018

BUY
$59.94 - $65.35 $542,696 - $591,678
9,054
9,054 $555,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cypress Wealth Services, LLC Portfolio

Follow Cypress Wealth Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Wealth Services, LLC with notifications on news.